Who should go first in trials with scarce agents? The views of potential participants.
Pentz RD, Flamm AL, Sugarman J, Cohen MZ, Xu Z, Herbst RS, Abbruzzese JL. Who should go first in trials with scarce agents? The views of potential participants. Ethics & Human Research 2007, 29: 1-6. PMID: 17847620.Peer-Reviewed Original Research